RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

Clinical trials for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS explained in plain language.

Never miss a new study

Get alerted when new RESPIRATORY SYNCYTIAL VIRUS INFECTIONS trials appear

Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 2 Not yet finished but already full! 3 Completed 7 Terminated 1

Pfizer halts early trial of new RSV drug for babies

Disease control Terminated

This study aimed to find a safe and effective dose of an experimental drug called sisunatovir for infants and young children (up to 5 years old) with serious RSV lung infections. It was a small, early-stage trial that compared the drug to a placebo to check for side effects and h…

Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

Get alerted when new RESPIRATORY SYNCYTIAL VIRUS INFECTIONS trials appear

Pfizer halts early trial of new RSV drug for babies